Rocket Fuel


    

Print    Email
Decrease (-) Restore Default Increase (+)

Chronic Myeloid Leukemia Clinical Trials

Please check with your doctor or call 1-855-HCH-HOPE to find out if you qualify for any of these studies.

Trial  #

Trial Sub-type

Title

CAMN107A US37

A phase II randomized, multicenter study of treatment-free remission in chronic myeloid leukemia in chronic phase (CML-CP) patients who achieve and sustain MR4.5 after
switching to nilotinib (Tasigna).

©  2014 

Holy Cross Hospital | 1500 Forest Glen Road, Silver Spring, MD 20910 | 301-754-7000